在系统性自身免疫性疾病中,怀孕期间对药物的坚持:从前性研究中得出的结果
Dina Zucchi1, Francesco Racca2, Linda Carli2
1Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, and Department of Medical Biotechnologies, University of Siena, Italy.
Clinical and experimental rheumatology
|October 9, 2023
概括
系统性自身免疫性疾病 (SAD) 中的药物坚持通常是好的,孕妇的比例略高. 然而,大约30%的患者难以坚持,这凸显了改善SAD患者监测策略的必要性.
科学领域:
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 系统性自身免疫性疾病 (SAD) 需要长期的药物管理.
- 药物坚持对于疾病控制和患者的治疗结果至关重要.
- 怀孕可以影响SAD妇女的药物坚持.
研究的目的:
- 为了比较怀孕和非怀孕妇女与SAD之间的药物坚持.
- 为了确定与这种人群中药物坚持相关的因素.
主要方法:
- 研究了一组200名SAD患者 (100名孕妇,100名非孕妇) 的队列.
- 使用莫里斯基药物坚持度表 (MMAS-8) 评估了药物坚持度.
- 使用医院焦虑和抑郁量表 (HADS) 测量焦虑和抑郁程度.
主要成果:
- 总体而言,观察到良好的药物坚持 (平均MMAS-8分数>6).
- 孕妇患者对氧化 (HCQ) 和其他类风湿治疗的坚持率有较高的趋势,尽管在统计学上不显著.
- 焦虑与非HCQ药物的较低坚持有关 (p=0.02);抑郁症没有显示出显著的关联.
结论:
- 在SAD队列中记录了对处方药物的良好坚持,但大约30%的患者对处方药的坚持不足.
- 识别患有不良粘附风险的患者仍然具有挑战性.
- 实施增强的沟通和监测策略,特别是在怀孕期间,可以改善SAD患者的药物坚持.
更多相关视频
相关概念视频
Autoimmune Disorders
471
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
471
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
178
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
178
Factors Affecting Drug Response: Overview
2.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
141
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
141
Inflammatory Bowel Disease IV: Pharmacological Management
137
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
137
Development of Immunocompetence
331
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
331


